Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skin Laboratory PCL's ROE % for the quarter that ended in Mar. 2026 was -31.95%. Skin Laboratory PCL's PB Ratio for the quarter that ended in Mar. 2026 was 1.76.
Skin Laboratory PCL's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -18.15%.
Skin Laboratory PCL ROE % Adjusted to Book Value Related Terms
Skin Laboratory PCL ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Skin Laboratory PCL's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Skin Laboratory PCL ROE % Adjusted to Book Value Chart
BKK:SKIN vs PG, CL, KVUE: ROE % Adjusted to Book Value Comparison
For the Household & Personal Products subindustry, Skin Laboratory PCL's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skin Laboratory PCL ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Skin Laboratory PCL's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -18.15% mean?
Skin Laboratory PCL (BKK:SKIN) has a ROE % Adjusted to Book Value of -18.15% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Skin Laboratory PCL and its competitors.
Is Skin Laboratory PCL's ROE % Adjusted to Book Value too high?
Skin Laboratory PCL's current ROE % Adjusted to Book Value is -18.15%. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's ROE % Adjusted to Book Value compare to PG and CL?
Skin Laboratory PCL's ROE % Adjusted to Book Value of -18.15% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Skin Laboratory PCL and its competitors. Skin Laboratory PCL's current ROE % Adjusted to Book Value is -18.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current ROE % Adjusted to Book Value of -18.15%. The current ROE % Adjusted to Book Value is -18.15%. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current ROE % Adjusted to Book Value is -18.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score
Get the complete analysis for BKK:SKIN
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKIN has been successfully added to your 
